Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Pharm Biomed Anal ; 47(1): 183-9, 2008 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-18313249

RESUMO

The focus of this study is identification, isolation and characterization of a principal oxidation impurity of clopidogrel which ranged from 0.05 to 0.12% using high performance liquid chromatography. This impurity is considered as principal oxidation impurity as it is observed in oxidative degradation (stress) study. Preparative HPLC with Xterra MS C18 ODB column was used to isolate the impurity. The isolated impurity was co-injected with the sample containing impurities and found the retention time match of the spiked impurities. A thorough study was undertaken to characterize this impurity and based on their spectral data (UV, MS, MSn 1H/13C, DEPT and 2D NMR) the structure was characterized as 5-[1-(2-chlorophenyl)-2-methoxy-2-oxoethyl]-6,7-dihydrothieno[3,2-c]pyridin-5-ium with a molecular weight 320 amu.


Assuntos
Contaminação de Medicamentos , Preparações Farmacêuticas/análise , Inibidores da Agregação Plaquetária/análise , Ticlopidina/análogos & derivados , Clopidogrel , Espectroscopia de Ressonância Magnética , Oxirredução , Espectrometria de Massas por Ionização por Electrospray , Ticlopidina/análise , Ticlopidina/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA